Skip to main content

Table 2 A comparison of the prevalence of foot symptoms and MFPDI scores in relation to work

From: Work participation, mobility and foot symptoms in people with systemic lupus erythematosus: findings of a UK national survey

 

In work N = 79

Reporting work non-participation N = 32

OR (95% CI)

P-value

N Reported

% of employed

N Reported

% of LTS/ Retired

Raynaud’s in past

42

53.8%

19

59.4%

1.25 (0.54–2.89)

0.265

Calf pain in past

44

55.7%

22

68.8%

1.75 (0.73–4.17)

0.107

Calf night pain in past

59

74.7%

27

87.1%

2.29 (0.71–7.34)

0.065

Loss of feeling in past

10

12.8%

11

34.4%

3.56 (1.33–9.55

0.053

Ulcer in past

16

20.5%

14

43.8%

3.01 (1.24–7.33)

0.018

Hard skin in past

56

72.7%

27

84.4%

2.03 (0.69–5.99)

0.165

Ingrown toenail in past

30

38.0%

16

51.6%

1.74 (0.75–4.03)

0.264

Reported Rash/Blisters

26

32.9%

13

41.9%

1.47 (0.63–3.46)

0.699

Difficulty walking in past

25

31.6%

18

58.1%

2.99 (1.27–7.04)

0.024

Swelling in past

37

46.8%

22

71.0%

2.78 (1.14–6.78)

0.041

Stiffness in past

62

79.5%

28

93.3%

3.61 (0.78–16.79)

0.063

Joint pain in past

64

82.1%

28

93.3%

3.06 (0.65–14.38)

0.155

Change in Foot shape in past

26

33.8%

12

42.9%

1.47 (0.61–3.57)

0.710

MFPDI function score

MAX 20

Mean

6.44

12.10

 

< 0.001

MFPDI pain score

MAX 10

Mean

3.05

4.52

 

0.018

MFPDI foot appearance score

MAX 4

Mean

0.72

1.57

 

0.038

MFPDI Total

MAX 34

Mean

10.16

18.13

 

< 0.001

  1. Results shown in table two include those adjusted for age